Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: MicroRNA Activation of LOX-1 Mechanisms in Endometriosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating microRNA activation of LOX-1 mechanisms in endometriosis was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Penn State University | Conditions: Endometriosis | Phase 4 | Status: TERMINATED | Results posted: 2024-02-28